The candidate is a pediatric hematologist and geneticist, with basic science training in biochemistry and molecular biology; and a clinical research background in pediatric blood, lipid, and vascular disorders. The primary short term goal for this award is to provide protected time for two ongoing genetic studies related to blood and vascular disease in pediatric populations. The major long-term goal is to establish the PI as a mentor for fellows interested in patient-related translational research in pediatric hematology, genetics, cardiology or nutrition. The study environment is the Hematology Division and the lipid clinic at Children's Hospital, Boston, a major center for training young investigators in pediatrics. The first project aims to elucidate genetic basis of the syndrome, Thiamine Responsive Megaloblastic Anemia (TRMA). By homozygosity mapping, the PI has mapped this recessive disorder to chromosome 1 (1q23.2-23.3). Fibroblasts from patients, but not controls, demonstrate cell death in thiamine deficient medium, due to defective high-affinity thiamine uptake. The working hypothesis for this study is that the TRMA gene encodes a mammalian thiamine transporter. Using a combination of positional and complementation cloning techniques, the gene for TRMA will be identified, and mutations sought in the DNA from patients. The function of the normal TRMA gene will be examined, and somatic defects in this gene will be sought among patients with related disorders, including marrow myelodysplasia. The second project is aimed at identifying gene(s) responsible for low levels of high-density lipoprotein (HDL) cholesterol by linkage analysis. Familial low HDL-C is a major contributor to early atherosclerosis. Patients with low HDL-C and a family history of premature heart disease have been ascertained in the setting of a pediatric lipid clinic. To date, 38 kindreds, including more than 600 individuals, have been enrolled, and a multicenter effort is underway to enroll 100 kindreds. Linkage will be sought to candidate genes related to HDL metabolism, and in genome-wide screens. Polymorphic markers for known or novel candidate genes identified in these studies will then be evaluated in broader populations. Both projects provide training opportunities for fellows in aspects of patient-focused science, ranging from cellular biochemistry approaches to metabolic disorders, to linkage analysis, to population studies of genetic polymorphisms.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
1K24HL004184-01
Application #
2898911
Study Section
Special Emphasis Panel (ZHL1-CSR-F (M3))
Project Start
1999-08-15
Project End
2004-07-31
Budget Start
1999-08-15
Budget End
2000-07-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Obeng, Esther A; Harney, Kathy M; Moniz, Thomas et al. (2015) Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system. J Pediatr 166:144-50
Morrison, Jacqueline F; Neufeld, Ellis J; Grace, Rachael F (2014) The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience. Eur J Haematol 93:161-4
Grace, Rachael F; Long, Michelle; Kalish, Leslie A et al. (2012) Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population. Pediatr Blood Cancer 58:216-20
Grace, Rachael F; Bennett, Carolyn M; Ritchey, A Kim et al. (2012) Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. Pediatr Blood Cancer 58:221-5
Long, Michelle; Kalish, Leslie A; Neufeld, Ellis J et al. (2012) Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects. Am J Hematol 87:315-7
Sobota, Amy; Graham, Dionne A; Neufeld, Ellis J et al. (2012) Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation. Pediatr Blood Cancer 58:61-5
Grace, Rachael F; Dahlberg, Suzanne E; Neuberg, Donna et al. (2011) The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol 152:452-9
Trenor 3rd, Cameron C; Chung, Richard J; Michelson, Alan D et al. (2011) Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics 127:347-57
Sobota, Amy; Neufeld, Ellis J; Sprinz, Philippa et al. (2011) Transition from pediatric to adult care for sickle cell disease: results of a survey of pediatric providers. Am J Hematol 86:512-5
Oyeku, Suzette O; Feldman, Henry A; Ryan, Kathleen et al. (2010) Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies. J Natl Med Assoc 102:676-82

Showing the most recent 10 out of 44 publications